Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity

Laboratory Investigation

Volumn 80, Issue 3, 2000, Pages 303-312

  Teramoto, Norihiro ^a   Maeda, Akihiko ^b   Kobayashi, Keita ^a   Hayashi, Kazuhiko ^a   Oka, Takashi ^a   Takahashi, Kiyoshi ^a   Takada, Kenzo ^a,c   Klein, Georg ^b   Akagi, Tadaatsu ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; VIRUS CARCINOGENESIS;

EID: 0034123983     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780035     Document Type: Article

References (26)

1. Anagnostopoulos I, Herbst H, Niedobitek G, and Stein H (1989). Demonstration of monoclonal EBV genomes in Hodgkin's disease and KI-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 74:810-816.
2. Chen F, Zou JZ, di Renzo L, Winberg G, Hu LF, Klein E, Klein G, and Ernberg I (1995). A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol 69:3752-3758.
3. Holmgren L, Szeles L, Rajnavolgyi E, Folkman J, Klein G, and Falk KI (1999). Horizontal transfer of Epstein-Barr virus DNA by uptake of apoptotic bodies. Blood 93:3956-3963.
4. Imai S, Nishikawa J, and Takada K (1998). Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72:4371-4378.
5. Jian WQ, Wendel-Hansen V, Lundkvist A, Ringertz N, Klein G, and Rosen A (1991). Intranuclear distribution of Epstein-Barr virus-encoded nuclear antigens EBNA-1,-2,-3, and -5. J Cell Sci 99:497-502.
6. Kieff E (1996). Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, and Howley PM, eds. Fields Virology. Philadelphia, PA: Lippincott-Raven, 2343-2396.
7. Klein G (1994). Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791-793.
8. Knox P, Li Q, Rickinson A, and Young L (1996). In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma. Virology 215:40-50.
9. Komano J, Sugiura M, and Takada K (1998). Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol 72:9150-9156.
10. Lin CT, Chan W, Chen W, Huang H, Wu H, Hsu M, Chuang S, and Wang C (1993). Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 68: 716-727.
11. Lin CT, Lin CR, Tan GK, Chen W, Dee AN, and Chan WY (1997). The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol 150:1745-1756.
12. Niedobitek G, Young LS, Lau R, Brooks L, Greenspan D, Greenspan JS, and Rickinson AB (1991). Epstein-Barr virus infection in oral hairy leukoplakia: Virus replication in the absence of a detectable latent phase. J Gen Virol 72:3035-3046.
13. Nishikawa J, Imai S, Oda T, Kojima T, Okita K, and Takada K (1999). Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol 73: 1286-1292.
14. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, and Raab-Traub N (1995). Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 146: 1355-1367.
15. Raab TN (1992). Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol 3:297-307.
16. Rickinson AB and Kieff E (1996). Epstein-Barr virus. In: Fields BN, Knipe DM, and Howley PM, eds. Fields Virology. Philadelphia, PA: Lippincott-Raven, 2397-2446.
17. Roth G, Curiel T, and Lacy J (1994). Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotides inhibits proliferation of Epstein-Barr virus-immortalized B cells. Blood 84: 582-587.
18. Rowe M, Lear AL, Croom CD, Davies AH, and Rickinson AB (1992). Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66: 122-131.
19. Saito I, Servenius B, Compton T, and Fox RI (1989). Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med 169:2191-2198.
20. Sheu L, Chen A, Meng C, Ho K, Lee W, Leu F, and Chao C (1996). Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. J Pathol 180:243-248.
21. Shimizu N, Yoshiyama H, and Takada K (1996). Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol 70:7260-7263.
22. Teramoto N, Akagi T, Yoshino T, Takahashi K, and Jong H (1992). Direct detection of Epstein-Barr Virus DNA from a single Reed-Sternberg cell of Hodgkin's disease by polymerase chain reaction. Jpn J Cancer Res 83:329-333.
23. Teramoto N, Sarker AB, Tonoyama Y, Yoshino T, Hayashi K, Takahashi K, and Akagi T (1996). Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies. Cancer 77:2339-2347.
24. Trivedi P, Masucci M, Winberg G, and Klein G (1991). The Epstein-Barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells. Int J Cancer 48:794-800.
25. Wang D, Liebowitz D, and Kieff E (1985). An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
26. Yoshiyama H, Imai S, Shimizu N, and Takada K (1997). Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 71:5688-5691.